Find Camostat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Camostat mesilate, 59721-29-8, Camostat (mesylate), Camostat methanesulfonate, Foipan, Camostate
Molecular Formula
C21H26N4O8S
Molecular Weight
494.5  g/mol
InChI Key
FSEKIHNIDBATFG-UHFFFAOYSA-N
FDA UNII
451M50A1EQ

Camostat
Camostat Mesylate is the mesylate salt form of camostat, an orally bioavailable, synthetic serine protease inhibitor, with anti-inflammatory, antifibrotic, and potential antiviral activities. Upon oral administration, camostat and its metabolite 4-(4-guanidinobenzoyloxyl)phenyl acetic acid (FOY 251) inhibit the activities of a variety of proteases, including trypsin, kallikrein, thrombin and plasmin, and C1r- and C1 esterases. Although the mechanism of action of camostat is not fully understood, trypsinogen activation in the pancreas is known to be a trigger reaction in the development of pancreatitis. Camostat blocks the activation of trypsinogen to trypsin and the inflammatory cascade that follows. Camostat may also suppress the expression of the cytokines interleukin-1beta (IL-1b), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a) and transforming growth factor-beta (TGF-beta), along with alpha-smooth muscle actin (alpha-SMA). This reduces inflammation and fibrosis of the pancreas. In addition, camostat may inhibit the activity of transmembrane protease, serine 2 (TMPRSS2), a host cell serine protease that mediates viral cell entry for influenza virus and coronavirus, thereby inhibiting viral infection and replication.
1 2D Structure

Camostat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate;methanesulfonic acid
2.1.2 InChI
InChI=1S/C20H22N4O5.CH4O3S/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22;1-5(2,3)4/h3-10H,11-12H2,1-2H3,(H4,21,22,23);1H3,(H,2,3,4)
2.1.3 InChI Key
FSEKIHNIDBATFG-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
451M50A1EQ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Camostat

2. Camostat Mesilate

3. Camostate

4. Camostate-mesilate

5. Foipan

6. Foy 305

7. Foy S 980

8. Foy-305

9. Foypan

10. N,n-dimethylcarbamoylmethyl-4-(4-guanidinobenzoyloxy)phenylacetate Methanesulfonate

11. P-guanidinobenzoic Acid, Ester With (p-hydroxyphenyl)acetic Acid, Ester With N,n-dimethylglycolamide

2.3.2 Depositor-Supplied Synonyms

1. Camostat Mesilate

2. 59721-29-8

3. Camostat (mesylate)

4. Camostat Methanesulfonate

5. Foipan

6. Camostate

7. Mfcd00941410

8. Foy305

9. Camostat Mesilate [jan]

10. Camostat Mesilate;foy305;foy-s980

11. Dsstox_cid_238

12. 4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate Methanesulfonate

13. Dsstox_rid_75452

14. Dsstox_gsid_20238

15. Chembl85164

16. 2-(dimethylamino)-2-oxoethyl 4-(4-guanidinobenzoyloxy)phenylacetate Methanesulphonate

17. Methanesulfonic Acid 4-{2-[(dimethylcarbamoyl)methoxy]-2-oxoethyl}phenyl 4-carbamimidamidobenzoate

18. 451m50a1eq

19. Cas-59721-29-8

20. Ncgc00167526-01

21. Foy-305

22. Foipan (tn)

23. Camostat Mesylate- Bio-x

24. Camostat Mesilate (jp17)

25. Mls006010697

26. Schembl871583

27. Foy-s980

28. Camostat Mesilate (foy-305)

29. Dtxsid0020238

30. Chebi:31347

31. Amy8832

32. Camostat Mesilate [mart.]

33. Hms3651d04

34. Camostat Mesilate [who-dd]

35. Bcp06708

36. Ex-a4154

37. Tox21_112523

38. Camostat Mesylate, >=98% (hplc)

39. S2874

40. Camostat Methanesulfonate [mi]

41. Akos015966692

42. Akos026750463

43. Tox21_112523_1

44. Ac-8540

45. Ccg-269652

46. Hs-0060

47. Ncgc00167526-02

48. 4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-((diaminomethylene)amino)benzoate Methanesulfonate

49. 4-[[4-[(aminoiminomethyl)amino]benzoyl]oxy]benzeneacetic Acid 2-(dimethylamino)-2-oxoethyl Ester Methanesulfonate

50. Bc164270

51. Hy-13512

52. Smr002530343

53. Sy060177

54. Db-072684

55. B2082

56. Ft-0648873

57. Sw219517-1

58. D01766

59. F20649

60. 721c298

61. A832436

62. Q-200778

63. Q23731028

64. 4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl4-guanidinobenzoatemethanesulfonate

65. 4-(2-{[2-(dimethylamino)-2-oxoethyl]oxy}-2-oxoethyl)phenyl 4-{[amino(imino)methyl]amino}benzoate Methanesulfonate

66. 4-{2-[(dimethylcarbamoyl)methoxy]-2-oxoethyl}phenyl 4-[(diaminomethylidene)amino]benzoate; Methanesulfonic Acid

2.4 Create Date
2005-11-20
3 Chemical and Physical Properties
Molecular Weight 494.5 g/mol
Molecular Formula C21H26N4O8S
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count9
Exact Mass494.14713497 g/mol
Monoisotopic Mass494.14713497 g/mol
Topological Polar Surface Area200 Ų
Heavy Atom Count34
Formal Charge0
Complexity695
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Trypsin Inhibitors

Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. (See all compounds classified as Trypsin Inhibitors.)


Protease Inhibitors

Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)


API SUPPLIERS

read-more
read-more

01

Jinan Tantu Chemicals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
American Pharma Summit
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jinan Tantu Chemicals

02

Laurus Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

American Pharma Summit
Not Confirmed
arrow

03

AR Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

American Pharma Summit
Not Confirmed
arrow

04

Sato Yakuhin Kogyo Co., Ltd

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

American Pharma Summit
Not Confirmed
arrow

Sato Yakuhin Kogyo Co., Ltd

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
American Pharma Summit
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

05

Fuji Chemical Industry

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

American Pharma Summit
Not Confirmed
arrow

Fuji Chemical Industry

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
American Pharma Summit
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

06

Sato Yakuhin Kogyo Co., Ltd

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

American Pharma Summit
Not Confirmed
arrow

Sato Yakuhin Kogyo Co., Ltd

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
American Pharma Summit
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

07

Prajna Generics

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

American Pharma Summit
Not Confirmed
arrow

Prajna Generics

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
American Pharma Summit
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Erregierre SpA

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

American Pharma Summit
Not Confirmed
arrow

Erregierre SpA

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
American Pharma Summit
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

09

Aurore Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

American Pharma Summit
Not Confirmed
arrow

Aurore Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
American Pharma Summit
Not Confirmed
USDMF CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
blank

10

Beijing Fukangren Biopharmaceutica...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

American Pharma Summit
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-more

01

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

Camostat mesylate

Registration Number : 229MF10164

Registrant's Address : VIA F. BARACCA 19-24060 SAN PAOLO D'ARGON (BERGAMO) ITALY

Initial Date of Registration : 2017-08-22

Latest Date of Registration : 2018-04-23

blank

02

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

Camostat mesilate (for manufacturing only)

Registration Number : 221MF10058

Registrant's Address : 55 Yokohoonji, Kamiichi-cho, Nakaniikawa-gun, Toyama Prefecture

Initial Date of Registration : 2009-03-19

Latest Date of Registration : 2009-03-19

blank

03

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

Japanese Pharmacopoeia Camostat Mesilate (for manufacturing only)

Registration Number : 219MF10222

Registrant's Address : 2-3-5 Shimookui, Toyama City, Toyama Prefecture

Initial Date of Registration : 2007-07-06

Latest Date of Registration : 2007-07-06

blank

04

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

Japanese Pharmacopoeia Camostat Mesilate (for manufacturing only)

Registration Number : 218MF10465

Registrant's Address : 2-3-5 Shimookui, Toyama City, Toyama Prefecture

Initial Date of Registration : 2006-04-27

Latest Date of Registration : 2006-04-27

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty